|
|
|
|
Can KLK7 be used to treat skin inflammation?
(Note: companies that
could be impacted by the content of this article are listed at the base of the
story [desktop version]. This article uses third-party references to provide a
bullish, bearish, and balanced point of view; sources are listed after the
Balanced section.)
Source: L. Furio and A. Hovnanian: Loss of kallikrein
inhibition in Netherton syndrome, Biol. Chem. 2014; 395(9): 945–958
Multiple publications show the importance of controlling KLK7, a serine protease, in healthy skin tissues. Notably, there are multiple products targeting KLK7 for the treatment of dermatological disorders.
